Citadel Advisors’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $272K | Buy |
256,431
+242,311
| +1,716% | +$257K | ﹤0.01% | 4714 |
|
|
2025
Q1 | $15.4K | Sell |
14,120
-93,768
| -87% | -$102K | ﹤0.01% | 5638 |
|
|
2024
Q4 | $163K | Sell |
107,888
-947,808
| -90% | -$1.43M | ﹤0.01% | 4968 |
|
|
2024
Q3 | $1.57M | Sell |
1,055,696
-660,778
| -38% | -$985K | ﹤0.01% | 2710 |
|
|
2024
Q2 | $2.78M | Buy |
1,716,474
+135,924
| +9% | +$220K | ﹤0.01% | 2134 |
|
|
2024
Q1 | $2.69M | Buy |
1,580,550
+350,200
| +28% | +$595K | ﹤0.01% | 2244 |
|
|
2023
Q4 | $3.81M | Sell |
1,230,350
-692,007
| -36% | -$2.15M | ﹤0.01% | 1854 |
|
|
2023
Q3 | $11.8M | Sell |
1,922,357
-204,464
| -10% | -$1.26M | ﹤0.01% | 1062 |
|
|
2023
Q2 | $13.3M | Buy |
2,126,821
+346,717
| +19% | +$2.17M | ﹤0.01% | 1031 |
|
|
2023
Q1 | $8.49M | Buy |
1,780,104
+404,005
| +29% | +$1.93M | ﹤0.01% | 1424 |
|
|
2022
Q4 | $12M | Buy |
1,376,099
+406,601
| +42% | +$3.54M | ﹤0.01% | 1175 |
|
|
2022
Q3 | $11.5M | Sell |
969,498
-440,580
| -31% | -$5.24M | ﹤0.01% | 1166 |
|
|
2022
Q2 | $20.1M | Buy |
1,410,078
+1,369,096
| +3,341% | +$19.5M | 0.01% | 841 |
|
|
2022
Q1 | $853K | Sell |
40,982
-119,570
| -74% | -$2.49M | ﹤0.01% | 3905 |
|
|
2021
Q4 | $3.71M | Buy |
160,552
+135,205
| +533% | +$3.12M | ﹤0.01% | 2396 |
|
|
2021
Q3 | $755K | Sell |
25,347
-101,288
| -80% | -$3.02M | ﹤0.01% | 4082 |
|
|
2021
Q2 | $4.33M | Buy |
126,635
+116,602
| +1,162% | +$3.98M | ﹤0.01% | 2329 |
|
|
2021
Q1 | $330K | Buy |
10,033
+3,878
| +63% | +$128K | ﹤0.01% | 4940 |
|
|
2020
Q4 | $379K | Sell |
6,155
-7,220
| -54% | -$445K | ﹤0.01% | 4065 |
|
|
2020
Q3 | $475K | Buy |
+13,375
| New | +$475K | ﹤0.01% | 3541 |
|